Mabe, Nathaniel W <br/><br/>
Epigenetic silencing of tumor suppressor Par-4 promotes chemoresistance in recurrent breast cancer.  [electronic resource] 

 -  The Journal of clinical investigation  10 2018 
 - 4413-4428 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1558-8238 
<br/><br/><label>Standard No.: </label>10.1172/JCI99481  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis Regulatory Proteins--biosynthesis<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Drug Resistance, Neoplasm<br/>Enhancer of Zeste Homolog 2 Protein--genetics<br/>Epithelial-Mesenchymal Transition<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Gene Silencing<br/>Histone Deacetylase 1--genetics<br/>Histone Deacetylase 2--genetics<br/>Humans<br/>Mice<br/>Mice, Nude<br/>Neoplasm Recurrence, Local--drug therapy<br/>Nuclear Proteins--genetics<br/>Tumor Suppressor Proteins--biosynthesis<br/>Twist-Related Protein 1--genetics